Back | Next |
home / stock / avxl / avxl message board
Subject | By | Source | When |
---|---|---|---|
No-one appears to have asked your chances of | Investor2014 | investorshub | 07/21/2024 5:08:10 PM |
Sorry. No pumpers / WGTers allowed. | BIOChecker4 | investorshub | 07/21/2024 5:04:01 PM |
Good point, I forgot about how many exclusions | kevindenver | investorshub | 07/21/2024 4:59:29 PM |
Yes, Dr Sabbagh interestingly makes that remark saying | williamssc | investorshub | 07/21/2024 4:53:01 PM |
This company seems to be stuck in the | kund | investorshub | 07/21/2024 4:12:22 PM |
Blarcamesine can compliment a MAB treatment by | tredenwater2 | investorshub | 07/21/2024 4:11:28 PM |
YES! Foundational science being laid/shared and by highly | tredenwater2 | investorshub | 07/21/2024 4:00:57 PM |
I would love to go - do you | Hoskuld | investorshub | 07/21/2024 3:29:36 PM |
I agree that the utility and opportunity for | boi568 | investorshub | 07/21/2024 2:51:37 PM |
Blarcamesine can compliment a MAB treatment by reducing | kevindenver | investorshub | 07/21/2024 2:42:00 PM |
Im leaving tonight for a 3-day FUDster convention | BIOChecker4 | investorshub | 07/21/2024 2:38:05 PM |
Take your dispute with Legend back to $NWBO board. | powerwalker | investorshub | 07/21/2024 2:03:09 PM |
Autophagy is a highly complex energy producing catabolic | KIPK | investorshub | 07/21/2024 1:07:09 PM |
I got the same inclination when listening to | tredenwater2 | investorshub | 07/21/2024 1:06:45 PM |
2-73 dislocates S1 from the MAM - hence | frrol | investorshub | 07/21/2024 12:50:19 PM |
Sabbagh's presentation for some reason emphasizes 2-73 being | Hoskuld | investorshub | 07/21/2024 12:37:23 PM |
I guess you have remained the Legend in | KIPK | investorshub | 07/21/2024 12:21:02 PM |
WOW! LTB, thanks for finding this and the | powerwalker | investorshub | 07/21/2024 10:06:16 AM |
Part of the fudster manifesto is try to | ignatiusrielly35 | investorshub | 07/21/2024 6:36:27 AM |
2-73 We can be safer. Just for one day.👏 | bb8675309 | investorshub | 07/21/2024 6:24:15 AM |
News, Short Squeeze, Breakout and More Instantly...
Anavex Life Sciences Corp. Company Name:
AVXL Stock Symbol:
NASDAQ Market:
Anavex Life Sciences Corp. Website:
Oral, once daily blarcamesine significantly slowed clinical decline for early Alzheimer's disease patients with good comparative safety profile and no associated neuroimaging adverse events Clinical benefit of blarcamesine consistently observed for both 30 mg and 50 mg treatment groups ...
2024-07-18 02:34:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative, neurodevelopmental and neuropsyc...